BE1002167A5 - Derives de l'adenosine. - Google Patents

Derives de l'adenosine. Download PDF

Info

Publication number
BE1002167A5
BE1002167A5 BE8801427A BE8801427A BE1002167A5 BE 1002167 A5 BE1002167 A5 BE 1002167A5 BE 8801427 A BE8801427 A BE 8801427A BE 8801427 A BE8801427 A BE 8801427A BE 1002167 A5 BE1002167 A5 BE 1002167A5
Authority
BE
Belgium
Prior art keywords
adenosine derivatives
compounds
relates
radical
ring
Prior art date
Application number
BE8801427A
Other languages
English (en)
French (fr)
Inventor
Brian Evans
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of BE1002167A5 publication Critical patent/BE1002167A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE8801427A 1987-12-23 1988-12-22 Derives de l'adenosine. BE1002167A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878729994A GB8729994D0 (en) 1987-12-23 1987-12-23 Chemical compounds

Publications (1)

Publication Number Publication Date
BE1002167A5 true BE1002167A5 (fr) 1990-08-28

Family

ID=10628947

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8801427A BE1002167A5 (fr) 1987-12-23 1988-12-22 Derives de l'adenosine.

Country Status (36)

Country Link
US (1) US5032583A (enExample)
EP (1) EP0322242B1 (enExample)
JP (1) JP2736088B2 (enExample)
KR (1) KR890009967A (enExample)
CN (1) CN1024198C (enExample)
AT (1) ATA315488A (enExample)
AU (2) AU612747B2 (enExample)
BE (1) BE1002167A5 (enExample)
CA (1) CA1320195C (enExample)
CH (1) CH677495A5 (enExample)
CZ (1) CZ403991A3 (enExample)
DE (2) DE3856154T2 (enExample)
DK (1) DK170894B1 (enExample)
ES (1) ES2012927A6 (enExample)
FI (1) FI90429C (enExample)
FR (1) FR2629715B1 (enExample)
GB (2) GB8729994D0 (enExample)
GR (1) GR1000307B (enExample)
HK (1) HK1009650A1 (enExample)
HU (1) HU203364B (enExample)
IE (1) IE61302B1 (enExample)
IL (1) IL88765A (enExample)
IT (1) IT1224840B (enExample)
LU (1) LU87414A1 (enExample)
MX (1) MX14331A (enExample)
NL (1) NL8803140A (enExample)
NO (1) NO171506C (enExample)
NZ (1) NZ227485A (enExample)
PH (1) PH25932A (enExample)
PL (1) PL158800B1 (enExample)
PT (1) PT89328B (enExample)
RU (2) RU1826971C (enExample)
SE (1) SE8804609L (enExample)
SG (1) SG44701A1 (enExample)
YU (1) YU234188A (enExample)
ZA (1) ZA889593B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2226027B (en) * 1988-12-13 1992-05-20 Sandoz Ltd Adenosine derivatives,their production and use
FR2665362B1 (fr) * 1990-08-03 1994-12-09 Cepbepe Substance contenant, comme principe actif, une adenosine substitutee en n6 et son application.
SG80526A1 (en) * 1990-09-25 2001-05-22 Rhone Poulenc Rorer Int Compounds having antihypertensive and anti- ischemic properies
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
GB9111580D0 (en) * 1991-05-30 1991-07-24 Wellcome Found Nucleoside derivative
DK62692D0 (enExample) * 1992-05-14 1992-05-14 Novo Nordisk As
US5672588A (en) * 1992-05-20 1997-09-30 Novo Nordisk A/S Purine derivatives
US5443836A (en) * 1993-03-15 1995-08-22 Gensia, Inc. Methods for protecting tissues and organs from ischemic damage
FI964468A0 (fi) * 1994-05-10 1996-11-06 Sandoz Ltd Adenosiinijohdannaisia
GB9421133D0 (en) * 1994-10-20 1994-12-07 Glaxo Group Ltd Medicaments
AU2022597A (en) * 1996-03-13 1997-10-01 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
AU2022497A (en) * 1996-03-13 1997-10-01 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
US6376472B1 (en) * 1996-07-08 2002-04-23 Aventis Pharmaceuticals, Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
NZ508314A (en) 1998-06-02 2004-03-26 Osi Pharm Inc Pyrrolo[2,3d]pyrimidine compositions and their use
US6686366B1 (en) 1998-06-02 2004-02-03 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6878716B1 (en) 1998-06-02 2005-04-12 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptor and uses thereof
US6784165B1 (en) * 1999-11-23 2004-08-31 Aderis Pharmaceuticals, Inc. Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines
US6680322B2 (en) 1999-12-02 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US6664252B2 (en) 1999-12-02 2003-12-16 Osi Pharmaceuticals, Inc. 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
US7160890B2 (en) 1999-12-02 2007-01-09 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6294522B1 (en) * 1999-12-03 2001-09-25 Cv Therapeutics, Inc. N6 heterocyclic 8-modified adenosine derivatives
GB9930077D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
GB9930083D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
US6673802B2 (en) 2000-12-01 2004-01-06 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6680324B2 (en) 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
GB0106867D0 (en) * 2001-03-20 2001-05-09 Glaxo Group Ltd Process
EP1258247A1 (en) * 2001-05-14 2002-11-20 Aventis Pharma Deutschland GmbH Adenosine analogues for the treatment of insulin resistance syndrome and diabetes
JP2005529062A (ja) 2001-11-30 2005-09-29 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド アデノシンａ１及びａ３受容体に特異的な化合物とその使用
EA007468B1 (ru) 2001-12-20 2006-10-27 Оси Фармасьютикалз, Инк. Пиримидиновые соединения, относящиеся к a-селективным антагонистам, их синтез и применение
US20030229067A1 (en) 2001-12-20 2003-12-11 Arlindo Castelhano Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use
EP1633371A1 (en) * 2003-04-24 2006-03-15 Aderis Pharmaceuticals, Inc. Method of treating atrial fibrillation or atrial flutter
TWI494102B (zh) * 2003-05-02 2015-08-01 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合
US20050118262A1 (en) * 2003-09-17 2005-06-02 Jack Aurora Controlled release formulation
JP5203214B2 (ja) * 2005-11-30 2013-06-05 イノテック ファーマシューティカルズ コーポレイション プリン化合物およびその使用方法
CN101712709A (zh) * 2008-10-06 2010-05-26 中国医学科学院药物研究所 三乙酰基-3-羟基苯基腺苷及其调血脂的用途
EP2473492B1 (en) 2009-08-31 2015-10-07 Lonza Ltd. Process for the preparation of (1s,4r)-2-oxa-3-azabicyclo[2,2.1]hept-5-enes
TWI744723B (zh) 2014-06-20 2021-11-01 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1552957A (enExample) * 1966-10-20 1969-01-10
FR1558462A (enExample) * 1966-12-21 1969-02-28
FR2239252A1 (enExample) * 1973-07-31 1975-02-28 Boehringer Mannheim Gmbh
EP0179667A2 (en) * 1984-10-26 1986-04-30 Warner-Lambert Company N6-substituted adenosines

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2052596A1 (de) * 1970-10-27 1972-05-04 Boehringer Mannheim Gmbh, 6800 Mannheim Neuartige Verwendung von N(6)-substituierten Adenosin-Derivaten
NL7203984A (enExample) * 1971-04-10 1972-10-12
BE788958A (fr) * 1971-09-18 1973-03-19 Schering Ag Derives d'adenosine et leur procede de preparation
DE2148838A1 (de) * 1971-09-30 1973-04-05 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2157036A1 (de) * 1971-11-17 1973-05-24 Boehringer Mannheim Gmbh Neue heterocyclisch substituierte nebularin-derivate und verfahren zu deren herstellung
DE2244328A1 (de) * 1972-09-09 1974-03-21 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2338963A1 (de) * 1973-08-01 1975-02-13 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2426682A1 (de) * 1974-06-01 1975-12-11 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
ZA857998B (en) * 1984-10-26 1986-05-28 Warner Lambert Co N6-substituted adenosines

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1552957A (enExample) * 1966-10-20 1969-01-10
FR1558462A (enExample) * 1966-12-21 1969-02-28
FR2239252A1 (enExample) * 1973-07-31 1975-02-28 Boehringer Mannheim Gmbh
EP0179667A2 (en) * 1984-10-26 1986-04-30 Warner-Lambert Company N6-substituted adenosines

Also Published As

Publication number Publication date
PL158800B1 (en) 1992-10-30
KR890009967A (ko) 1989-08-05
IE883845L (en) 1989-06-23
RU1826971C (ru) 1993-07-07
CN1024198C (zh) 1994-04-13
DK713488A (da) 1989-06-24
JPH01203400A (ja) 1989-08-16
AU2740188A (en) 1989-06-29
JP2736088B2 (ja) 1998-04-02
HUT48903A (en) 1989-07-28
MX14331A (es) 1993-12-01
FR2629715B1 (fr) 1993-09-03
SE8804609L (sv) 1989-06-24
FI885943L (fi) 1989-06-24
PH25932A (en) 1991-12-19
GB2212498A (en) 1989-07-26
SG44701A1 (en) 1997-12-19
DE3843609A1 (de) 1989-07-06
NO171506C (no) 1993-03-24
IT8848714A0 (it) 1988-12-23
PL276697A1 (en) 1990-02-19
RU2060996C1 (ru) 1996-05-27
CA1320195C (en) 1993-07-13
PT89328B (pt) 1993-08-31
ATA315488A (de) 1994-02-15
HU203364B (en) 1991-07-29
NO885719L (no) 1989-06-26
PT89328A (pt) 1989-12-29
SE8804609D0 (sv) 1988-12-21
IT1224840B (it) 1990-10-24
GB8729994D0 (en) 1988-02-03
FI90429C (fi) 1994-02-10
CN1035295A (zh) 1989-09-06
LU87414A1 (fr) 1989-07-07
IE61302B1 (en) 1994-10-19
FI90429B (fi) 1993-10-29
DK713488D0 (da) 1988-12-21
DE3856154T2 (de) 1998-08-27
EP0322242B1 (en) 1998-04-01
FR2629715A1 (fr) 1989-10-13
GR1000307B (el) 1992-05-12
ES2012927A6 (es) 1990-04-16
NO171506B (no) 1992-12-14
NO885719D0 (no) 1988-12-22
US5032583A (en) 1991-07-16
YU234188A (en) 1990-12-31
AU612747B2 (en) 1991-07-18
GB2212498B (en) 1991-07-24
AU8589491A (en) 1991-12-12
EP0322242A2 (en) 1989-06-28
CZ403991A3 (en) 1993-04-14
EP0322242A3 (en) 1990-04-18
HK1009650A1 (en) 1999-06-04
ZA889593B (en) 1989-09-27
NL8803140A (nl) 1989-07-17
IL88765A (en) 1993-04-04
GB8829983D0 (en) 1989-02-15
NZ227485A (en) 1991-06-25
DE3856154D1 (de) 1998-05-07
CH677495A5 (enExample) 1991-05-31
IL88765A0 (en) 1989-07-31
DK170894B1 (da) 1996-03-04

Similar Documents

Publication Publication Date Title
BE1002167A5 (fr) Derives de l'adenosine.
BE903103A (fr) Derives heterocycliques
CA2014518A1 (fr) Lipopolyamines, leur preparation et leur emploi
FR2372176A1 (fr) Procede de preparation de derives d'alcoxy-3 androstanones-17
KR880007471A (ko) 살균제 피리딜 이미데이트와 이를 이용한 살균제 조성물 및 억제방법
BE1002211A4 (fr) (pentamethyl-1,2,2,6,6 piperidyl-4-amino)-triazines, leur application comme stabilisants de matieres organiques, et compositions qui en contiennent.
CA2207835A1 (fr) Nouveaux derives du 3-(piperid-4-yl) 1,2-benzisoxazole et du 3-(piperazin-4-yl) 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
BE903183A (fr) Nouveaux derives du benzonorbornene, leurs procedes de preparation et composition medicamenteuse et cosmetique les contenant
TNSN07178A1 (fr) N-sulfonylaminobenzyl-2-phenoxy-acetamides substitues
CA2023645A1 (fr) Procede pour la preparation enantioselective de derives de la phenylisoserine
BE900855A (fr) Compositions pour le traitement prophylactique de l'osteite et de l'osteomyelite.
FI914187A0 (fi) Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta
BE900275A (fr) Azetidinones.
FR2637183A1 (fr) Nouveaux inhibiteurs de la biosynthese du cholesterol et leur preparation
BE902306A (fr) Derives de la 2-1,2,4-triazoline-5-one et compositions herbicides en contenant.
FR2637286A1 (fr) Nouveaux derives benzoxazolinoniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2636946A1 (fr) ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant
CO4700291A1 (es) Compuestos quimicos
BE904641A (fr) 5-pyrimidine-carboxamides et traitement de la leucemie et des tumeurs avec ces derniers.
HUT44038A (en) Process for production of 6 or 7-methylene-androsta-1,4-diene-3,17-dion and medical compounds containing them
KR900001673A (ko) N-치환 아미드 유도체
EP0366561A3 (fr) Nouveaux dérivés 1-azabicycloalkanes, leur procédé de préparation et leur application comme médicaments
FR2447375A1 (fr) Analogues de la prostaglandine e1 et compositions pharmaceutiques les contenant
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
BE1002236A4 (fr) Nouveaux derives de benzylidene-cyclanones, leur procede de preparation, leur utilisation en tant qu'agents anti-oxydants et comme filtres solaires, compositions cosmetiques et pharmaceutiques les contenant.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *GLAXO GROUP LTD

Effective date: 20081222